Balance Sheet
| IN CR | MAR 2026 | MAR 2025 | MAR 2007 | MAR 2006 | MAR 2005 | MAR 2004 |
|---|---|---|---|---|---|---|
| SOURCES OF FUNDS | ||||||
| Share Capital | 13.23 | 13.23 | 14.39 | 14.39 | 12.45 | 12.45 |
| Share warrants and Outstandings | 0.00 | 0.00 | 0.95 | 0.95 | 0.00 | 0.00 |
| Total Reserve | 592.12 | 517.30 | 57.18 | 51.44 | 2.61 | 24.33 |
| Shareholder's Funds | 605.35 | 530.53 | 72.52 | 66.77 | 15.06 | 36.78 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured Loans | 13.33 | 0.00 | 75.51 | 83.50 | 141.94 | 147.77 |
| Unsecured Loans | 0.00 | 0.00 | 9.38 | 13.68 | 14.50 | 17.24 |
| Total Debts | 20.00 | 0.00 | 84.88 | 97.19 | 156.44 | 165.01 |
| Total Liabilities | 629.53 | 537.98 | 157.40 | 163.96 | 171.50 | 201.79 |
| APPLICATION OF FUNDS : | ||||||
| Gross Block | 321.10 | 276.05 | 93.47 | 92.58 | 87.14 | 85.98 |
| Less: Accumulated Depreciation | 124.56 | 104.22 | 54.88 | 50.47 | 44.89 | 40.24 |
| Less: Impairment of Assets | 0.00 | 0.00 | 12.47 | 12.47 | 12.47 | 0.00 |
| Net Block | 196.54 | 171.83 | 26.12 | 29.63 | 29.78 | 45.74 |
| Lease Adjustment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 23.29 | 16.06 | 11.97 | 0.13 | 1.71 | 1.80 |
| Pre-operative Expenses pending | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Assets in transit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 97.75 | 129.57 | 89.84 | 94.90 | 134.48 | 135.59 |
| Current Assets, Loans and Advances | ||||||
| Inventories | 123.84 | 92.98 | 19.27 | 23.34 | 27.79 | 25.50 |
| Sundry Debtors | 116.68 | 86.76 | 24.42 | 25.43 | 22.51 | 24.91 |
| Cash and Bank | 191.56 | 139.61 | 8.19 | 27.29 | 0.70 | 1.06 |
| Other Current Assets | 15.58 | 10.11 | 0.67 | 0.61 | 2.57 | 1.67 |
| Loans and Advances | 27.92 | 9.89 | 16.43 | 17.94 | 15.19 | 15.68 |
| Total Current Assets | 559.48 | 465.25 | 68.99 | 94.60 | 68.75 | 68.81 |
| Less : Current Liabilities and Provisions | ||||||
| Current Liabilities | 32.97 | 24.33 | 6.59 | 6.24 | 23.15 | 17.32 |
| Provisions | 30.35 | 16.11 | 4.97 | 14.27 | 6.04 | 3.46 |
| Total Current Liabilities | 160.57 | 119.83 | 42.49 | 58.45 | 66.70 | 54.49 |
| Net Current Assets | 398.91 | 345.42 | 26.50 | 36.15 | 2.06 | 14.32 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.17 | 0.51 | 1.38 |
| Deferred Tax Assets by Liabilities | 3.06 | -1.00 | -2.97 | -2.97 | -2.97 | -2.97 |
| Total Assets | 629.53 | 537.98 | 157.40 | 163.96 | 171.50 | 201.79 |
| Contingent Liabilities | 17.79 | 13.63 | 139.24 | 15.57 | 98.92 | 172.82 |
SOURCES OF FUNDS
Share Capital
Share warrants and Outstandings
Total Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Total Debts
Total Liabilities
APPLICATION OF FUNDS :
Gross Block
Less: Accumulated Depreciation
Less: Impairment of Assets
Net Block
Lease Adjustment
Capital Work in Progress
Pre-operative Expenses pending
Assets in transit
Investments
Current Assets, Loans and Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Loans and Advances
Total Current Assets
Less : Current Liabilities and Provisions
Current Liabilities
Provisions
Total Current Liabilities
Net Current Assets
Miscellaneous Expenses not written off
Deferred Tax Assets by Liabilities
Total Assets
Contingent Liabilities
FAQs
What are the Total Assets of Rpg Life Sciences in the recent year?
The total assets of Rpg Life Sciences in the most recent year are ₹629.53 crore. This is a cumulative figure comprising both current and non-current assets, representing resources that provide future economic benefits.
What is the Total Liability of Rpg Life Sciences in the recent financial year?
As per the latest financial reports, the total liabilities of Rpg Life Sciences in March 2026 are ₹629.53 crore. This figure represents the total amount owed by the company, including short-term and long-term obligations. While some liabilities are normal, increasing liabilities without corresponding growth in earnings and assets may indicate weak financial health.
What are the Contingent Liabilities of Rpg Life Sciences in the financial year 2026?
Rpg Life Sciences has accounted for ₹17.79 crore as contingent liabilities in the recent financial year. This indicates potential losses that may arise in the future due to specific uncertain events.
What is the Capital Work-in-Progress of Rpg Life Sciences in the financial year 2026?
In the financial year 2026, Rpg Life Sciences has ₹23.29 crore as Capital Work-in-Progress. This metric represents costs associated with assets that are under construction or development but not yet ready for their intended use.
Can I invest in Rpg Life Sciences shares with Anand Rathi?
Yes! If you are already registered with Anand Rathi, you can buy Rpg Life Sciences stocks through the TradeMobi Trading App or the Web Trading Platform.If you are new to Anand Rathi, follow these steps to open a demat account:
- Fill out the form with basic details.
- Upload the requested documents (ID proof, address proof, PAN card, and bank details) for verification.
- Complete the eKYC process online.
- Activate your account and start investing seamlessly through our trading app or web platform.